Tirzepatide lowers weight across all groups with obesity
The antiobesity medication semaglutide “took things up one big notch, and now tirzepatide is up a little notch above that,” one expert said.
Link between PCOS and increased risk of pancreatic cancer?
“These data suggest some individuals may have unknown metabolic derangements that may underlie the development of both conditions.”
STEP TEENS: Semaglutide ‘gives hope’ to adolescents with obesity
“We are getting close to bariatric surgery results” in these adolescent patients with obesity. To have 40% of patients attain normal weight, “that...
ObesityWeek 2022: What’s stopping effective treatment of obesity?
In the biggest international conference on obesity, delegates will discuss obesity in children and barriers to use of newer anti-obesity drugs,...
Risk factors ID’d for acute pancreatitis from weight-loss drugs
“With obesity being such a global issue, there are many patients on these GLP-1 agonists.”
Don’t be afraid of weight gain with hyperthyroid treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
It’s about location: PCOS symptoms differ depending where you live
Women with PCOS in California were more likely to have hyperandrogenemia than were those in Alabama, but age and BMI weren’t factors, nor was race...
Weight loss history affects success in obesity management
A retrospective study yields a surprising finding about the weight-loss success of older women with experience in dieting.
Tirzepatide’s benefits expand: Lean mass up, serum lipids down
New results from the SURMOUNT-1 trial of tirzepatide in people with obesity show further positive effects.
Playing the fat shame game in medicine: It needs to stop
One study has suggested that over 40% of adults in the United States have suffered from weight stigma, and physicians and coworkers are listed as...